274 related articles for article (PubMed ID: 22790794)
1. Novel electrophysiological properties of dronedarone: inhibition of human cardiac two-pore-domain potassium (K2P) channels.
Schmidt C; Wiedmann F; Schweizer PA; Becker R; Katus HA; Thomas D
Naunyn Schmiedebergs Arch Pharmacol; 2012 Oct; 385(10):1003-16. PubMed ID: 22790794
[TBL] [Abstract][Full Text] [Related]
2. Carvedilol targets human K2P 3.1 (TASK1) K+ leak channels.
Staudacher K; Staudacher I; Ficker E; Seyler C; Gierten J; Kisselbach J; Rahm AK; Trappe K; Schweizer PA; Becker R; Katus HA; Thomas D
Br J Pharmacol; 2011 Jul; 163(5):1099-110. PubMed ID: 21410455
[TBL] [Abstract][Full Text] [Related]
3. Class I antiarrhythmic drugs inhibit human cardiac two-pore-domain K(+) (K2 ₂p) channels.
Schmidt C; Wiedmann F; Schweizer PA; Becker R; Katus HA; Thomas D
Eur J Pharmacol; 2013 Dec; 721(1-3):237-48. PubMed ID: 24070813
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of cardiac two-pore-domain K+ (K2P) channels by the antiarrhythmic drug vernakalant--comparison with flecainide.
Seyler C; Li J; Schweizer PA; Katus HA; Thomas D
Eur J Pharmacol; 2014 Feb; 724():51-7. PubMed ID: 24374008
[TBL] [Abstract][Full Text] [Related]
5. The human cardiac K2P3.1 (TASK-1) potassium leak channel is a molecular target for the class III antiarrhythmic drug amiodarone.
Gierten J; Ficker E; Bloehs R; Schweizer PA; Zitron E; Scholz E; Karle C; Katus HA; Thomas D
Naunyn Schmiedebergs Arch Pharmacol; 2010 Mar; 381(3):261-70. PubMed ID: 19777211
[TBL] [Abstract][Full Text] [Related]
6. Vernakalant activates human cardiac K(2P)17.1 background K(+) channels.
Seyler C; Schweizer PA; Zitron E; Katus HA; Thomas D
Biochem Biophys Res Commun; 2014 Aug; 451(3):415-20. PubMed ID: 25108155
[TBL] [Abstract][Full Text] [Related]
7. Identification and functional characterization of zebrafish K(2P)10.1 (TREK2) two-pore-domain K(+) channels.
Gierten J; Hassel D; Schweizer PA; Becker R; Katus HA; Thomas D
Biochim Biophys Acta; 2012 Jan; 1818(1):33-41. PubMed ID: 21963410
[TBL] [Abstract][Full Text] [Related]
8. Effect of dronedarone on Na+, Ca2+ and HCN channels.
Bogdan R; Goegelein H; Ruetten H
Naunyn Schmiedebergs Arch Pharmacol; 2011 Apr; 383(4):347-56. PubMed ID: 21279331
[TBL] [Abstract][Full Text] [Related]
9. Cardiac K
Staudacher I; Seehausen S; Illg C; Lugenbiel P; Schweizer PA; Katus HA; Thomas D
Prog Biophys Mol Biol; 2019 Jul; 144():128-138. PubMed ID: 31182191
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of cardiac two-pore-domain K+ (K2P) channels--an emerging antiarrhythmic concept.
Schmidt C; Wiedmann F; Schweizer PA; Katus HA; Thomas D
Eur J Pharmacol; 2014 Sep; 738():250-5. PubMed ID: 24927994
[TBL] [Abstract][Full Text] [Related]
11. Pharmacologic TWIK-Related Acid-Sensitive K+ Channel (TASK-1) Potassium Channel Inhibitor A293 Facilitates Acute Cardioversion of Paroxysmal Atrial Fibrillation in a Porcine Large Animal Model.
Wiedmann F; Beyersdorf C; Zhou X; Büscher A; Kraft M; Nietfeld J; Walz TP; Unger LA; Loewe A; Schmack B; Ruhparwar A; Karck M; Thomas D; Borggrefe M; Seemann G; Katus HA; Schmidt C
J Am Heart Assoc; 2020 May; 9(10):e015751. PubMed ID: 32390491
[TBL] [Abstract][Full Text] [Related]
12. Regulation of two-pore-domain (K2P) potassium leak channels by the tyrosine kinase inhibitor genistein.
Gierten J; Ficker E; Bloehs R; Schlömer K; Kathöfer S; Scholz E; Zitron E; Kiesecker C; Bauer A; Becker R; Katus HA; Karle CA; Thomas D
Br J Pharmacol; 2008 Aug; 154(8):1680-90. PubMed ID: 18516069
[TBL] [Abstract][Full Text] [Related]
13. Acute effects of dronedarone on both components of the cardiac delayed rectifier K+ current, HERG and KvLQT1/minK potassium channels.
Thomas D; Kathofer S; Zhang W; Wu K; Wimmer AB; Zitron E; Kreye VA; Katus HA; Schoels W; Karle CA; Kiehn J
Br J Pharmacol; 2003 Nov; 140(5):996-1002. PubMed ID: 14517175
[TBL] [Abstract][Full Text] [Related]
14. New Targets for Old Drugs: Cardiac Glycosides Inhibit Atrial-Specific K
Schmidt C; Wiedmann F; Gaubatz AR; Ratte A; Katus HA; Thomas D
J Pharmacol Exp Ther; 2018 Jun; 365(3):614-623. PubMed ID: 29643254
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular pharmacology of K
Staudacher I; Illg C; Chai S; Deschenes I; Seehausen S; Gramlich D; Müller ME; Wieder T; Rahm AK; Mayer C; Schweizer PA; Katus HA; Thomas D
Naunyn Schmiedebergs Arch Pharmacol; 2018 Oct; 391(10):1119-1131. PubMed ID: 30008082
[TBL] [Abstract][Full Text] [Related]
16. Identification and functional characterization of zebrafish K
Staudacher I; Illg C; Gierten J; Seehausen S; Schweizer PA; Katus HA; Thomas D
Eur J Pharmacol; 2018 Jul; 831():94-102. PubMed ID: 29753045
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of K(2P)3.1 K+ Current Causes Action Potential Shortening in Patients With Chronic Atrial Fibrillation.
Schmidt C; Wiedmann F; Voigt N; Zhou XB; Heijman J; Lang S; Albert V; Kallenberger S; Ruhparwar A; Szabó G; Kallenbach K; Karck M; Borggrefe M; Biliczki P; Ehrlich JR; Baczkó I; Lugenbiel P; Schweizer PA; Donner BC; Katus HA; Dobrev D; Thomas D
Circulation; 2015 Jul; 132(2):82-92. PubMed ID: 25951834
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of volatile and intravenous anesthetics on the activity of human TASK-1.
Putzke C; Hanley PJ; Schlichthörl G; Preisig-Müller R; Rinné S; Anetseder M; Eckenhoff R; Berkowitz C; Vassiliou T; Wulf H; Eberhart L
Am J Physiol Cell Physiol; 2007 Oct; 293(4):C1319-26. PubMed ID: 17699638
[TBL] [Abstract][Full Text] [Related]
19. TWIK-1 and TREK-1 are potassium channels contributing significantly to astrocyte passive conductance in rat hippocampal slices.
Zhou M; Xu G; Xie M; Zhang X; Schools GP; Ma L; Kimelberg HK; Chen H
J Neurosci; 2009 Jul; 29(26):8551-64. PubMed ID: 19571146
[TBL] [Abstract][Full Text] [Related]
20. Effects of the novel amiodarone-like compound SAR114646A on cardiac ion channels and ventricular arrhythmias in rats.
Goegelein H; Gautier P; Roccon A; O'Connor S; Ruetten H
Naunyn Schmiedebergs Arch Pharmacol; 2011 Sep; 384(3):231-44. PubMed ID: 21766160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
